-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis , is currently an increasingly popular intestinal disease worldwide
Inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis , is currently an increasingly popular intestinal disease worldwide
By visiting the Danish National Medical Insurance, the researchers identified all IBD patients and all urolithiasis cases in Denmark from 1977 to 2018, and obtained information on all IBD medications and surgical procedures from 1995 to 2018 at the same time
In this study, there were a total of 75,236 IBD patients, of which 2,549 (3%) had urolithiasis, and 11,258 (2%) of 767,403 non-IBD individuals had urolithiasis.
This study confirmed that the risk of urolithiasis in patients with IBD increased by a factor of two, and the risk of urolithiasis before the diagnosis of IBD increased by 42%
This study confirmed that the risk of urolithiasis in patients with IBD increased by a factor of two, and the risk of urolithiasis before the diagnosis of IBD increased by 42%
Henrik Dimke.
Risk of Urolithiasis in Patients With Inflammatory Bowel Disease: A Nationwide Danish Cohort Study 1977–2018.
Leave a message here